#AstraZeneca for the first time admits its Covishield vaccine may lead to rare side effect
20963 Tuesday, 30 April, 2024, 23:24 AstraZeneca has admitted for the first time in court documents that its Covid-19 vaccine, sold globally under the brand names Covishield and Vaxzevria among others, may lead to a rare side-effect. Covishield can cause, in rare cases, a condition that leads to blood clots and low platelet count, the vaccine-maker has said in court documents. This condition is known as Thrombosis with Thrombocytopenia Syndrome (TTS). Covishield was produced by the Serum Institute of India and widely administered in the country. AstraZeneca is facing a class action lawsuit in the UK over claims that its vaccine caused deaths and severe injuries in several cases. |
Doctors remove live cockroach from intestine after Delhi man complains of stomach ache (photo)
956720.10.2024, 18:54The horrifying details of the “newborn gang” scandal in Türkiye have rocked the nation
944719.10.2024, 01:06'Out of darkness, can come light': Kate's message in full (video)
1066609.09.2024, 22:12Over 70 factories in Ashulia shut down amid workers’ protests
1129504.09.2024, 20:24First children in Gaza given polio vaccine
944401.09.2024, 00:30Mpox cases are rising in Australia’s eastern states
1009616.08.2024, 10:48WHO: Monkey pox, global public health emergency
955715.08.2024, 11:12Chinese network accused of stealing thousands of corpses to use bones for dental grafts
993309.08.2024, 19:24